According to our limited data, GIST patients with both ALK expression and PDGFRA mutation tend to have a larger tumor diameter, higher recurrence risk and more mitotic figures, indicating that ALK expression may be associated with a worse prognosis. This evidence concerns the gene PDGFRA and gastrointestinal stromal tumor.